Global Restless Legs Syndrome Market Size, Competitive Analysis, Share, Forecast- 2020-2026

1. Orion Market Research Global Restless Legs Syndrome Market Size, Competitive Analysis, Share, Forecast- 2020-2026 Request a Free Sample @ https://www.omrglobal.com/request-sample/restless-legs- syndrome-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

2. The global restless legs syndrome market is projected to grow at a CAGR of 6.2% during the forecast period. The increase in the prevalence of restless legs syndrome (RLS) is a key factor responsible for the growth of the market. RLS is a disorder that is associated with the part of the nervous system that causes patients an urge to move the legs restlessly. According to the estimation of the National Institute of Neurological Disorders and Stroke (NIH), around 7-10 % of the US population has RLS. Moreover, the rising geriatric population further boosts the growth of the global market. As per the UN (United Nations), by 2050 around 1 in 6 (16%) citizens will be over the age of 65 years, globally, which was 1 in 11 (9%) in 2019. Old age, obesity, and snoring conditions lead to an increase in the rate of various types of sleep disorders which will create significant demand for diagnosis and treatment for obstructive sleep-wake disorders shortly. Get Free Sample Copy @https://www.omrglobal.com/request-sample/restless-legs- syndrome-market However, the high cost of drugs and therapy used for the treatment of restless leg syndrome coupled with low healthcare budget in some developing countries may hinder the growth of the market. For instance, the annual cost of Rotigotine (Neupro), a drug to treat used to treat restless legs syndrome and periodic limb movement disorder can cost up to $5,300 per year in the US. Huge R&D expenditure by market players for the development of the novel intervention is anticipated to create a considerable opportunity for market growth. Browse for Full Report Description@https://www.omrglobal.com/industry-reports/restless- legs-syndrome-market Market Segmentation Global Restless Leg Syndrome Market by Treatment Medication Therapy Devices

3. Global Restless Legs Syndrome Market by End-User Hospitals Homecare Others Regional Analysis North America US Canada Europe UK Germany Italy Spain France Rest of Europe Asia-Pacific China India Japan Rest of Asia-Pacific Rest of the World Company Profiles Akorn, Inc.

4. Arbor Pharmaceuticals, LLC Boehringer Ingelheim GmbH GlaxoSmithKline plc Glenmark Pharmaceuticals Ltd. Jazz Pharmaceuticals plc Kyowa Hakko Kirin Co. Ltd. LGM Pharma Mallinckrodt Pharmaceuticals Merck Co, Inc. Mylan N.V. Pfizer, Inc. Serina Therapeutics, Inc. Teva Pharmaceutical Industries, Ltd. UCB S.A. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/restless-legs-syndrome-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404